Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/CoStim> ?p ?o }
Showing triples 1 to 30 of
30
with 100 triples per page.
- CoStim abstract "CoStim was a biotechnology company based in Cambridge, Massachusetts whose focus was cancer immunotherapy, that is, drugs that harnessed a patient’s own immune system. In particular, the company sought drugs that blocked the signals from cancer that shut down the immune response. One of the products the company worked on targeted the immune checkpoint molecule PD1. The company was involved in monoclonal antibody drug development.oStim was founded in 2012 by the venture capital firm MPM Capital as well as cancer researchers from the Dana–Farber Cancer Institute and Brigham and Women's Hospital. Later Atlas Venture also invested in the company.CoStim was acquired by the major pharmaceutical company Novartis for an undisclosed sum in February 2014.".
- CoStim wikiPageID "46603044".
- CoStim wikiPageLength "1164".
- CoStim wikiPageOutDegree "12".
- CoStim wikiPageRevisionID "666978900".
- CoStim wikiPageWikiLink Atlas_Venture.
- CoStim wikiPageWikiLink Biotechnology.
- CoStim wikiPageWikiLink Brigham_and_Womens_Hospital.
- CoStim wikiPageWikiLink Cambridge,_Massachusetts.
- CoStim wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- CoStim wikiPageWikiLink Dana–Farber_Cancer_Institute.
- CoStim wikiPageWikiLink Immune_checkpoint.
- CoStim wikiPageWikiLink Immunotherapy.
- CoStim wikiPageWikiLink MPM_Capital.
- CoStim wikiPageWikiLink Monoclonal_antibody.
- CoStim wikiPageWikiLink Novartis.
- CoStim wikiPageWikiLink Programmed_cell_death_protein_1.
- CoStim wikiPageWikiLinkText "CoStim".
- CoStim wikiPageUsesTemplate Template:Refimprove.
- CoStim wikiPageUsesTemplate Template:Reflist.
- CoStim subject Category:Biotechnology_companies_of_the_United_States.
- CoStim hypernym Company.
- CoStim type Company.
- CoStim comment "CoStim was a biotechnology company based in Cambridge, Massachusetts whose focus was cancer immunotherapy, that is, drugs that harnessed a patient’s own immune system. In particular, the company sought drugs that blocked the signals from cancer that shut down the immune response. One of the products the company worked on targeted the immune checkpoint molecule PD1.".
- CoStim label "CoStim".
- CoStim sameAs Q20715636.
- CoStim sameAs m.013674s5.
- CoStim sameAs Q20715636.
- CoStim wasDerivedFrom CoStim?oldid=666978900.
- CoStim isPrimaryTopicOf CoStim.